Shared Experience: The Next Frontier in Precision Oncology

Title: The Next Frontier in Precision Oncology

Date: Thursday 29 January 2026 | 17:00–18:30

In-person Location: Riverside House 2A Southwark Bridge Rd, London SE1 9HA 

Also available to join us online

Co-hosts: HCA, Madano and Women in Pharma

Speakers:

1. Dr Berna Özdemir — Senior Medical Oncology Consultant, University Hospital Bern; Founding Member, ESMO Gender Medicine Taskforce

2. Linda Geddes — Health Writer, The Guardian

3. Merel Hennink — Secretary of the Board, Cancer Patients Europe (CPE) and Board Member, Lung Cancer Europe (LuCE)

Description:

For the past two decades, the pursuit of precision has transformed cancer care — delivering treatments that are smarter, more targeted, and increasingly personal.

Real progress has been made — yet outcomes still vary widely. Understanding why patients respond so differently is key to reaching the next frontier.

This hybrid session will explore the next frontier in precision oncology: understanding the human factors that shape how cancer develops, progresses, and responds to treatment. It will look at the biological, behavioural, and social variables still underrepresented in cancer research and care — and how clinical, communications, and policy approaches can work together to close these gaps and drive lasting change.

A thought-provoking and practical session for anyone working in healthcare communications, policy, or oncology — followed by networking and refreshments.